You searched for: philadelphiakromosomet (Danska - Engelska)

philadelphiakromosomet findes hos nogle patienter med all og hos de fleste patienter med cml.
the philadelphia-chromosome is found in some all patients and is present in most patients with cml.

de foretagne undersøgelser viser, at bosulif er effektivt til at nedsætte andelen af hvide blodlegemer med philadelphiakromosomet.
studies have been carried out to show that bosulif is effective at reducing the proportion of white blood cells with the philadelphia chromosome.

bosulif anvendes, når patienten er positiv for "philadelphiakromosomet" (ph-positiv).
bosulif is used in patients who are ‘philadelphia-chromosome positive’ (ph+).

det betyder, at nogle af patientens gener har omarrangeret sig, så de danner et specielt kromosom, der kaldes philadelphiakromosomet.
this means that some of their genes have re-arranged themselves to form a special chromosome called the philadelphia chromosome.

det betyder, at der ikke er sket en omarrangering af nogle af deres gener til det specielle kromosom kaldet philadelphiakromosomet, som findes hos nogle patienter med all.
this means that some of their genes are not re-arranged forming a special chromosome called the philadelphia chromosome, which is found in some patients with all.

ph+ betyder, at nogle af patientens gener har omarrangeret sig og dannet et specielt kromosom kaldet philadelphiakromosomet, der medfører udvikling af leukæmi.
ph+ means that some of the patient’s genes have rearranged themselves to form a special chromosome called the philadelphia chromosome that leads to the development of leukaemia.

· voksne og børn med nydiagnosticeret philadelphiakromosom (bcr-abl) positiv (ph+) kronisk
· adult and paediatric patients with newly diagnosed philadelphia chromosome (bcr-abl) positive